These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 20051635)

  • 21. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor initiation in human malignant melanoma and potential cancer therapies.
    Ma J; Frank MH
    Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
    Winquist RJ; Boucher DM; Wood M; Furey BF
    Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
    Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting cancer stem cells.
    Kvinlaug BT; Huntly BJ
    Expert Opin Ther Targets; 2007 Jul; 11(7):915-27. PubMed ID: 17614760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells.
    Hu X; Cong Y; Luo HH; Wu S; Zhao LE; Liu Q; Yang Y
    Stem Cells Transl Med; 2017 Feb; 6(2):331-334. PubMed ID: 28191780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches.
    Di Francesco AM; Toesca A; Cenciarelli C; Giordano A; Gasbarrini A; Puglisi MA
    J Cell Physiol; 2016 Oct; 231(10):2081-7. PubMed ID: 26791139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of cancer stem cells in the treatment of cancer.
    Pan CX; Zhu W; Cheng L
    Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.
    O'Flaherty JD; Barr M; Fennell D; Richard D; Reynolds J; O'Leary J; O'Byrne K
    J Thorac Oncol; 2012 Dec; 7(12):1880-1890. PubMed ID: 23154562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of Disease: cancer stem cells--targeting the evil twin.
    Trumpp A; Wiestler OD
    Nat Clin Pract Oncol; 2008 Jun; 5(6):337-47. PubMed ID: 18431377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cell targeted agents: therapeutic approaches and consequences.
    Chumsri S; Burger AM
    Curr Opin Mol Ther; 2008 Aug; 10(4):323-33. PubMed ID: 18683096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells and human malignant melanoma.
    Schatton T; Frank MH
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
    Fábián Á; Vereb G; Szöllősi J
    Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation.
    Brossa A; Grange C; Mancuso L; Annaratone L; Satolli MA; Mazzone M; Camussi G; Bussolati B
    Oncotarget; 2015 May; 6(13):11295-309. PubMed ID: 25948774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of Cancer Stem Cells by Using Synthetic Small Molecules: Toward New Therapeutic Strategies against Therapy Resistance.
    Maucort C; Di Giorgio A; Azoulay S; Duca M
    ChemMedChem; 2021 Jan; 16(1):14-29. PubMed ID: 32803855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.